由于过时的数据,FDA 删除了更年期激素治疗的黑盒警告,并引用了安全性和益处的新证据. FDA removes black box warning on menopausal hormone therapy due to outdated data, citing new evidence of safety and benefits.

林业发展局正在取消关于更年期妇女以雌激素为基础的激素治疗的黑盒警告,根据2002年一项研究中过时的、有缺陷的数据,要求发出先前的警告。 The FDA is removing the black box warning on estrogen-based hormone treatments for menopausal women, calling the previous warning based on outdated, flawed data from a 2002 study. 这一变化反映了新的证据表明,现代低剂量荷尔蒙疗法——特别是从更年期开始——能够降低乳腺癌、心脏病、痴呆症和骨折的风险,从而有可能增加生命年限。 The change reflects newer evidence showing that modern, lower-dose hormone therapies—especially when started near menopause—can reduce risks of breast cancer, heart disease, dementia, and fractures, potentially adding years to life. 此举旨在纠正长期存在的错误观念,改善获得安全治疗的机会,如阴道雌激素奶油,并支持循证护理。 The move aims to correct long-standing misconceptions, improve access to safe treatments like vaginal estrogen creams, and support evidence-based care.